Delmege Group continues to expand and diversify

Lewis Brown Pharmaceuticals, a subsidiary of the Delmege Group have been appointed by Kotra Pharma [M] Sdn Bhd, one of Malaysia's top five pharmaceutical companies to represent their products locally.

In Sri Lanka for the launch ceremony were Head of Sales and Marketing for International Markets, Cheah Ming Loong and Business Development Manager for Asia & Africa Markets, Tan Poh Huat of Kotra Pharma.

Today we launch two important brands to the Sri Lankan market together with our local representatives, Lewis Brown Pharmaceuticals, for the treatment of infectious diseases, namely Axcel which represents the oral and topical antibiotics and Vaxcel which specialises in injectable antibiotics. According to the WHO, infectious diseases are the leading cause of death and disability in this part of the world', said Cheah, speaking at the launch.

Lewis Brown Pharmaceuticals [LBP], the newly incorporated subsidiary of the Delmege Group to tap into the fast growing pharmaceutical industry, offers local representation to foreign principals seeking a local presence.

'The vision of LBP is to be among the top five marketing, distribution and logistics providers of pharmaceutical and healthcare services/ products in the country', said Group Director, Delmege & Forsyth Co, Shamil Mendis.

General Manager, LBP, Rajeev Ariaratnam, said that the Company offered the services of medical marketing, market knowledge, medical detailing and promotions, through a well qualified team who have experience in representing many multinational, as well as branded generic foreign principals.